⌘K

Home/Filings/4/0001064901-25-000002

4//SEC Filing

KAY CHRISTINA 4

Accession 0001064901-25-000002

CIK 0001016504other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 5:30 PM ET

Size

5.5 KB

Accession

0001064901-25-000002

Insider Transaction Report

Form 4

Period: 2025-12-09

INTEGRATED BIOPHARMA INCINBP

DirectorExecutive Vice President

Transactions

Award
Stock Option (Right to Buy)
2025-12-09+140,000→ 140,000 total
Exercise: $0.35Exp: 2035-12-09→ Common Stock (140,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1

filerCIK 0001064901

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 5:30 PM ET
Size: 5.5 KB

View on SEC.gov